Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

National Healthcare (NHC) Acquisitions (2016 - 2024)

National Healthcare's Acquisitions history spans 8 years, with the latest figure at $215.9 million for Q3 2024.

For Q3 2024, Acquisitions changed N/A year-over-year to $215.9 million; the TTM value through Dec 2025 reached $215.9 million, changed 0.0%, while the annual FY2024 figure was $215.9 million, 7896.15% up from the prior year.
Acquisitions reached $215.9 million in Q3 2024 per NHC's latest filing, up from $231000.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $215.9 million in Q3 2024 to a low of $215.9 million in Q3 2024.